腎組織慢性化病變分級(jí)及非典型溶血尿毒綜合征和C3腎病的最新專(zhuān)家共識(shí)
發(fā)布時(shí)間:2018-03-18 11:06
本文選題:慢性化 切入點(diǎn):C 出處:《腎臟病與透析腎移植雜志》2017年04期 論文類(lèi)型:期刊論文
【摘要】:正隨著循證醫(yī)學(xué)證據(jù)增多,腎臟疾病診斷和治療中亟待解決的一些問(wèn)題的答案也日益浮出水面。總結(jié)這些證據(jù),可以指導(dǎo)臨床實(shí)踐;發(fā)現(xiàn)其不足,提出進(jìn)一步研究策略,不僅需要扎實(shí)的理論基礎(chǔ),更需要豐富的臨床經(jīng)驗(yàn)。多學(xué)科專(zhuān)家組的共識(shí)無(wú)疑是對(duì)循證學(xué)證據(jù)最好的解讀和總結(jié)。眾所周知,在腎活檢病理中慢性化病變程度的評(píng)估對(duì)于判斷預(yù)后、指導(dǎo)治療具有重要意義,但目前尚缺乏統(tǒng)一規(guī)范的分級(jí)標(biāo)準(zhǔn)。2017年Kidney
[Abstract]:As evidence of evidence-based medicine increases, answers to questions that need to be solved in the diagnosis and treatment of kidney diseases are emerging. Summing up the evidence can guide clinical practice, discover its shortcomings, and propose further research strategies. It requires not only a solid theoretical foundation, but also a wealth of clinical experience. There is no doubt that the consensus of the multidisciplinary expert group is the best interpretation and summary of evidence-based evidence. The evaluation of the degree of chronic pathological changes in renal biopsy is of great significance in judging the prognosis and guiding the treatment, but there is still a lack of a unified and standardized grading standard. In 2017, Kidney
【作者單位】: 南京總醫(yī)院腎臟科國(guó)家腎臟疾病臨床醫(yī)學(xué)研究中心全軍腎臟病研究所;
【分類(lèi)號(hào)】:R692
【相似文獻(xiàn)】
相關(guān)期刊論文 前2條
1 羅振亞;腎炎的慢性化及防治[J];日本醫(yī)學(xué)介紹;1988年02期
2 張孝友;馬元起;劉樹(shù)德;;自家疫苗對(duì)慢性化膿性皮膚病的療效觀察[J];西安交通大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);1959年02期
,本文編號(hào):1629311
本文鏈接:http://sikaile.net/yixuelunwen/mjlw/1629311.html
最近更新
教材專(zhuān)著